Serum Osteopontin Level as Biomarker in the Diagnosis of Pediatric Bronchial Asthma in Different Age Groups | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 65, Volume 88, Issue 1, July 2022, Pages 2704-2709 PDF (654.22 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2022.241121 | ||
| Authors | ||
| Mohammed Sanad Nagiub; Ehab Mahmoud Rasheed; Atef Goda Hussein; Ahmed Ibraheem Abd El Hameed Atya* | ||
| Abstract | ||
| Background: Bronchial asthma is chronic inflammatory disease of the respiratory tract, in which many cells of innate and adaptive immune system in combination with epithelial cells are involved causing the main clinical typical criteria for the disease. Osteopontin (OPN) is identified in many cell types in the immune system. OPN is a protein expressed during the inflammatory processes related to Th2 lymphocyte activity. Objective: The aim of the current study was to evaluate serum osteopontin level as biomarker in the diagnosis of bronchial asthma in different age groups. Patients and Methods: This prospective case-control study was carried out at the Pediatric Department, Zagazig University Hospitals from May 2019 till December 2019. All patients were subjected to full history taking and laboratory investigations including measurement of Human Osteopontin (OPN). Results: There was high significant positive correlation between osteopontin and S. IgE and AEC. Also, there was high significant negative correlation between osteopontin and forced expiratory volume 1 (FEV1), forced vital capacity (FVC) and peak expiratory flow (PEF) in both age groups. There was significant difference between <5 years severe asthma and 5-12 years severe asthma as regard Osteopontin level. Conclusion: It could be concluded that there is strong association between OPN concentration and disease severity. OPN shows high significant difference between asthmatic and control group. Serum OPN is a good biomarker in the diagnosis of bronchial asthma at different age groups. | ||
| Keywords | ||
| Osteopontin; Biomarker; Diagnosis; Bronchial asthma; Pediatric | ||
|
Statistics Article View: 203 PDF Download: 340 |
||
